Belite Bio
IPOPublic · United States · $275.0M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- belitebio.com
- Total Funding
- $275.0M
- Last Round
- $275.0M Private EquityJan 2025
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company advancing novel therapeutics targeting retinal degenerative eye diseases.
Summary
Belite Bio is a Biotech company based in United States. It has raised $275.0M in total across 1 round, most recently a $275.0M Private Equity round in Jan 2025. Investors include RA Capital Management, Eventide Asset Management and Marshall Wace.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...